StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
TIL

Instil Bio, Inc.

TIL Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗
$7.25
+0.03 +0.42%

Key statistics

from XBRL data in SEC filings
Market cap
$49.2M
Revenue (TTM)
$0.00
Net income (TTM)
-$47.4M
EPS (TTM)
$-7.00
P/E ratio
Dividend yield
Free cash flow
Cash
$5.02M
Total assets
$200M
Gross margin
52-week range
$5.67 – $33.83

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Shareholder vote results Jun 11, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Results of operations (earnings release) May 15, 2026 8-K Changed accountants Apr 3, 2026 10-K Fiscal year ended 2025-12-31 Mar 27, 2026 8-K Results of operations (earnings release) Mar 27, 2026 8-K Terminated a material agreement Jan 6, 2026 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release) Nov 13, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Results of operations (earnings release) Aug 13, 2025 8-K Other events Jul 31, 2025 8-K Shareholder vote results May 28, 2025 8-K Regulation FD disclosure; Other events May 27, 2025 8-K Regulation FD disclosure May 22, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release) May 13, 2025 8-K Entered a material agreement Mar 31, 2025 10-K Fiscal year ended 2024-12-31 Mar 4, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Mar 4, 2025 8-K Other events Jan 14, 2025 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation Dec 23, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Results of operations (earnings release) Nov 13, 2024 8-K Regulation FD disclosure; Other events Sep 16, 2024 8-K Exit or disposal costs Sep 6, 2024 8-K Regulation FD disclosure Aug 15, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Results of operations (earnings release) Aug 13, 2024 8-K Entered a material agreement Aug 1, 2024 8-K Entered a material agreement Jul 11, 2024 8-K Shareholder vote results Jun 17, 2024 10-Q Quarter ended 2024-03-31 May 10, 2024 8-K Results of operations (earnings release) May 10, 2024 8-K Director or officer change Apr 26, 2024 10-K Fiscal year ended 2023-12-31 Mar 21, 2024 8-K Results of operations (earnings release) Mar 21, 2024 8-K Director or officer change Feb 14, 2024 8-K Other events Jan 18, 2024 8-K Exit or disposal costs; Other events Jan 16, 2024